Search clinical trials for: SolAeroMed

Total 5 results

SolAeroMed Inc.

Not yet recruiting

Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.

Post Acute COVID-19 Syndrome | Long COVID | COVID-19 Respiratory Infection
SolAeroMed Inc.

Recruiting

Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis

Bronchiectasis | Cystic Fibrosis

Canada
SolAeroMed Inc.

Suspended

Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia

Covid19 | SARS-CoV-2 Infection

Canada
SolAeroMed Inc.

Completed

Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma (S-1226(8%))

Asthma

Canada
SolAeroMed Inc.

Completed

Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects.

Asthma

3

Subscribe